Zusammenfassung
Mit der Zunahme des Lebensalters ist für Patienten die Zunahme eines Operationsrisikos verbunden. Daher müssen Risikopatienten frühzeitig identifiziert sowie einer perioperativen Diagnostik und Therapie kardialer Vorerkrankungen zugeführt werden. Hierzu existieren Risikoindizes (Goldman-Score, Eagle-Kriterien) und Richtlinien der American Heart Association (AHA/ACC). Grundlage ist die Einstufung des Patienten anhand des Operationsrisikos und der Vorerkrankungen. Wird eine weitere, häufig invasive Therapie geplant, so ist der Zeitraum, um den die Operation verschoben werden kann, entscheidend. Zum Nachweis kardialer Risikoreduktion müssen extrakardiale Operationen um mindestens 3 Monate verschoben werden. Ist dieser Zeitraum nicht einzuhalten, kann eine Risikominimierung in vielen Fällen durch eine β-Blocker-Therapie erreicht werden. Eine Arbeitsgruppe des Marburger Klinikums hat zu diesem Thema eigene Lösungsstrategien entwickelt, die im Folgenden ausgeführt werden.
Abstract
The older the patient, the higher the risk of perioperative cardiac complications. Therefore, patients at risk have to be identified and the appropriate diagnostic or therapeutic measures initiated. The most important factor in this context is whether a planned surgery can be postponed. Several strategies have been developed (e.g. Goldman index, Eagle criteria) and the American Heart Association (AHA/ACC) has produced guidelines concerning perioperative diagnosis and therapy of cardiac risk patients. The common goal of these strategies is always the risk classification of the patient by combining the operative risk and the risk factors of the patient. The further procedure (diagnostic or therapeutic measures) is based on the risk classification. If further invasive therapy proves to be necessary, the determining factor is the period of time for which the operation can be delayed. This appears to be about 3 months but if this is not possible the outcome could be improved with a β-blocker therapy in advance. A working group from the university hospital in Marburg has developed a strategy for risk classification and further diagnostic and therapeutic measures as outlined in this article.
Literatur
Ashton CM, Petersen NJ, Wray NP et al. (1993) The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1118:504–510
Baron JF, Mundler O, Bertrand M et al. (1994) Dipyridamol-thallium-scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 330:663–669
Boersma E, Poldermans D, Bax JJ et al. (2001) Predictors of cardiac events after major vascular surgery. Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 285:1865–1873
Bronson D, Halperin A, Marwick T (1995) Evaluating cardiac risk in noncardiac surgery patients. Cleve Clin J Med 62:391–400
Brown KA, Rowen M (1993) Extent of jeopardized viable myocardium determined by myocardial perfusion imaging best predicts perioperative cardiac events in patients undergoing noncardiac surgery. J Am Coll Cardiol 21:325–330
Bry JD, Belkin M, O’Donell TF Jr et al. (1994) An assessment of the positive predictive value and cost-effectiveness of dipyridamole myocardial scintigraphy in patients undergoing vascular surgery. J Vasc Surg 19:112–124
Chassot PG, Delabays A, Spahn DR (2002) Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing noncardiac surgery. Br J Anaesth 89:747–759
Detsky AS, Abrams HB, McLaughlin JR et al. (1986) Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1:211–219
Eagle KA, Coley CM, Newell JB et al. (1989) Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 110:859–866
Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ (1997) Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3,368 operations. CASS Investigators and University of Michigan Heart care program. Coronary artery surgery study. Circulation 96:1882–1887
Eagle KA, Berger PB, Calkins H et al. (2002) ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary. Circulation 105:1257–1267
Eichelberger JP, Schwarz KQ, Black ER, Green RM, Ouriel K (1993) Predictive value of dobutamine stress echocardiography just before noncardiac vascular surgery. Am J Cardiol 72:602–607
Foster ED, Davis KB, Carpentier JA, Abele S, Fray D (1986) Risk of noncardiac operation in patients with defined coronary artery disease: The Coronary Artery Surgery Study (CASS) registry experience. Ann Thorac Surg 41:42–50
Gauss A, Röhm HJ, Schäuffelen A et al. (2001) Electro-cardiographic exercise stress testing for cardiac risk assessment in patients undergoing noncardiac surgery. Anesthesiology 94:38–46
Gilbert K, Larocque BJ, Patrick LT (2000) Prospective evaluation of cardiac risk indices for patients undergoing noncardiac surgery. Ann Intern Med 133:356–359
Goldman L, Caldera D, Nussbaum S et al. (1977) Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 297:845–850
Halm EA, Browner WS, Tubau JF, Tateo IM, Mangano DT (1996) Echocardiography for assessing cardiac risk in patients having noncardiac surgery. Ann Intern Med 125:433–441
Hendel RC, Whitfield SS, Villegas BJ et al. (1992) Prediction of late cardiac events by dipyramidole thallium imaging in patients undergoing elective vascular surgery. Am J Cardiol 70:1243–1249
Hertzer NR (1987) Basic data concerning coronary disease in peripheral vascular patients. Ann Vasc Surg 1:616–620
Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE (2000) Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35:1288–1294
Khuri SF, Daley J, Henderson W et al. (1995) The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care. J Am Coll Surg 180:519–531
Krone RJ, Laskey WK, Johnson C, Kimmel SE et al. (2000) A simplified lesion classification for predicting success and complications of coronary angioplasty. Am J Cardiol 85:1179–1184
Landesberg G, Einav S, Christopherson R et al. (1997) Perioperative ischemia and cardiac complications in major vascular surgery: importance of the perioperative twelve-lead electrocardiogram. J Vasc Surg 26:570–578
Larsen SF, Oelsen KH, Jacobsen E et al. (1987) Prediction of cardiac risk in noncardiac surgery. Eur Heart J 8:179–185
Laskey WK, Kimmel SE, Krone RJ, Johnson C (2000) Contemporary trends in coronary intervention: a report from the registry of the society for cardiac angiography and interventions. Catheter Cardiovasc Interv 49:19–22
Lette J, Waters D, Bernier H et al. (1992) Preoperative and long-term cardiac risk assessment. Predictive value of 23 clinical descriptors, 7 multivariate scoring systems, and quantitative dipyridamole imaging in 360 patients. Ann Surg 216:192–204
Lette J, Waters D, Cerino M et al. (1992) Preoperative coronary artery disease risk stratification based on dipyramidole imaging, and a simple three-step, three-segment model for patients undergoing noncardiac vascular surgery or major general surgery. Am J Cardiol 69:1553–1558
Mangano DT (1990) Perioperative cardiac morbidity. Anesthesiology 72:153–184
Mangano DT, Goldman L (1995) Preoperative assessment of patients with known or suspected coronary artery disease. N Engl J Med 333:1750–1756
Mangano DT, Browner WS, Hollenberg M et al. (1990) Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 323:1781–1788
Mangano DT, Wong MG, London MJ et al. (1991) Perioperative myocardial ischemia in patients undergoing noncardiac surgery—II: Incidence and severity during the first week after surgery. J Am Coll Cardiol 17:851–857
Mangano DT, Layug EI, Wallace A, Tateo I (1996) Multicenter study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 335:1713–1720
Mantha S (2000) Rational cardiac risk stratification before peripheral vascular surgery: application of evidence-based medicine and Bayesian analysis. Semin Cardiothorac Vasc Anesth 4:198–212
Mantha S, Roizen MF, Barnard J, et al. (1994) Relative effectiveness of four preoperative tests for predictive adverse cardiac outcome after vascular surgery. Anesth Analg 79:422–433
McCann RL, Wolfe WG (1989) Resection of abdominal aortic aneurysm in patients with low ejection fraction. J Vasc Surg 10:240–244
McFalls EO, Doliszny KM, Grund F et al. (1993) Angina and persistent exercise thallium defects: independent risk factors in elective vascular surgery. J Am Coll Cardiol 21:1347–1352
Nishina K, Mikawa K, Uesugi T et al. (2002) Efficacy of clonidine for prevention of perioperative myocardial ischemia: a critical approach and meta-analysis of literature. Anesthesiology 96:323–329
Palda VA, Detsky AS (1997) Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med 127:313–328
Pasternak P, Grossi E, Baumann G et al. (1989) The value of silent myocardial ischemia monitoring in the prediction of perioperative myocardial infarction in patients undergoing peripheral vascular surgery. J Vasc Surg 10:617–625
Paul SD, Eagle KA, Kuntz KM et al. (1996) Concordance of preoperative clinical risk with angiographic severity of coronary artery disease in patients undergoing vascular surgery. Circulation 94:1561–1566
Poldermans D, Arnese M, Fioretti P et al. (1995) Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol 26:648–653
Poldermans D, Boersma E, Bax JJ et al. (1999) Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341:1789–1794
Posner KL, Norman GA van, Chan V (1999) Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty. Anesth Analg 89:553–560
Raby KE, Goldman L, Creager MA et al. (1989) Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med 321:1296–1300
Raby KE, Brull SJ, Timimi F et al. (1999) The effect of heart rate control on myocardial ischemia among high risk patients after vascular surgery. Anesth Analg 88:477–482
Schein OD, Katz J, Bass EB et al. (2000) The value of routine preoperative medical testing before cataract surgery. N Engl J Med 342:168–175
Shah KB, Kleinman BS, Rao TLK et al. (1990) Angina and other risk factors in patients with cardiac diseases undergoing noncardiac operations. Anesth Analg 70:240–247
Shaw LJ, Eagle KA, Gersh BJ, Miller DD (1996) Meta-analysis of intravenous dipyridamole thallium-201 imaging (1985 to 1994) and dobutamine stress echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol 27:787–798
Tresch D (1995) Diagnostic and prognostic value of ambulatory electrographic monitoring in older patients. J Am Geriatr Soc 43:66–70
Vanzetto G, Machecourt J, Blendea D et al. (1996) Additive value of thallium single-photon emission computed tomography myocardial imaging for prediction of perioperative events in clinically selected high cardiac risk patients having abdominal aortic surgery. Am J Cardiol 77:143–148
Wallace A, Layug B, Tateo I et al. (1998) Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology 88:7–17
Younis L, Stratmann H, Takase B et al. (1994) Preoperative clinical assessment and dipyridamole thallium-210 scintigraphy for prediction and prevention of cardiac events in patients having major noncardiovascular surgery and known or suspected coronary artery disease. Am J Cardiol 1994; 74:311–317
Zeldin RA (1984) Assessing cardiac risk in patients who undergo noncardiac surgical procedures. Can J Surg 27:402–404
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kratz, C.D., Christ, M., Maisch, B. et al. Prämedikationsvisite. Anaesthesist 53, 862–870 (2004). https://doi.org/10.1007/s00101-004-0709-x
Issue Date:
DOI: https://doi.org/10.1007/s00101-004-0709-x